Calixarenes as new platforms for drug design
Calixarenes, macrocyclic compounds of phenolic units linked by methylene groups at the 2,6-positions, present some of the requirements to serve as platforms for the design and synthesis of biological active compounds. They are also interesting host molecules for chemical biology study purposes. Thei...
Saved in:
Published in: | Current drug discovery technologies Vol. 6; no. 2; p. 151 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
United Arab Emirates
01-06-2009
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Calixarenes, macrocyclic compounds of phenolic units linked by methylene groups at the 2,6-positions, present some of the requirements to serve as platforms for the design and synthesis of biological active compounds. They are also interesting host molecules for chemical biology study purposes. Their basic molecular scaffold has potential ability for molecule recognition; it is promptly synthesized in large amounts, and might be easily modified for maximizing molecular interactions toward relevant guest molecules. Calixarenes present well-defined conformational properties and cavities with molecular dimensions that enable to encapsulate guest drugs. Calixarenes have been shown to have antiviral, antibacterial, antifungal, and anticancer activities (including HIV as target). We provide here an overview of the use of calixarenes either as new chemical entity of distinct biological activities or as host for bioactive guest molecules. The importance of calixarenes for drugs development is discussed. The use of Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) techniques for the study of calixarenes as biological molecule hosts is also described. |
---|---|
AbstractList | Calixarenes, macrocyclic compounds of phenolic units linked by methylene groups at the 2,6-positions, present some of the requirements to serve as platforms for the design and synthesis of biological active compounds. They are also interesting host molecules for chemical biology study purposes. Their basic molecular scaffold has potential ability for molecule recognition; it is promptly synthesized in large amounts, and might be easily modified for maximizing molecular interactions toward relevant guest molecules. Calixarenes present well-defined conformational properties and cavities with molecular dimensions that enable to encapsulate guest drugs. Calixarenes have been shown to have antiviral, antibacterial, antifungal, and anticancer activities (including HIV as target). We provide here an overview of the use of calixarenes either as new chemical entity of distinct biological activities or as host for bioactive guest molecules. The importance of calixarenes for drugs development is discussed. The use of Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) techniques for the study of calixarenes as biological molecule hosts is also described. |
Author | Sabino, Adão Aparecido de Fátima, Angelo Fernandes, Sergio Antonio |
Author_xml | – sequence: 1 givenname: Angelo surname: de Fátima fullname: de Fátima, Angelo email: adefatima@qui.ufmg.br organization: Grupo de Estudos em Química Orgânica e Biológica (GEQOB), Departamento de Química, ICEx, UFMG, Avenida Presidente Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, MG, 31270-901, Brazil. adefatima@qui.ufmg.br – sequence: 2 givenname: Sergio Antonio surname: Fernandes fullname: Fernandes, Sergio Antonio – sequence: 3 givenname: Adão Aparecido surname: Sabino fullname: Sabino, Adão Aparecido |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19519339$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jstKAzEYRrOo2Iu-gAvJAzj6_7lnKYM3KLhp1yUxSRmZSYekRX17R9TNd-AsDt-SzPIhR0KuEG4ZanGHUgMqDlYbI4zhwGZk8SObyZo5Wdb6DsCsVuaczNFKtJzbBblpXd99uhJzrNRVmuMHHXt3TIcyVDotDeW0pyHWbp8vyFlyfY2Xf1yR7ePDpn1u1q9PL-39uvFT89iwIDSLjEMSKSiGIKVzQYQkUUlgKiYUCYM0CN4qxb2V4s16CdwZ4BrZilz_dseTH2LYjaUbXPna_d9m36n3Qss |
CitedBy_id | crossref_primary_10_1007_s10847_012_0161_5 crossref_primary_10_1039_c0cc05662f crossref_primary_10_1039_C1NJ20636B crossref_primary_10_3390_pharmaceutics11060292 crossref_primary_10_1007_s10847_013_0372_4 crossref_primary_10_1016_j_antiviral_2010_09_009 crossref_primary_10_1016_j_tet_2022_132816 crossref_primary_10_1016_S1004_9541_13_60628_X crossref_primary_10_1080_00268976_2017_1347295 crossref_primary_10_1111_jam_13658 crossref_primary_10_1002_anie_201206785 crossref_primary_10_1016_j_tet_2012_09_032 crossref_primary_10_1016_j_bbamcr_2013_07_010 crossref_primary_10_1016_j_cplett_2017_12_023 crossref_primary_10_1039_c3ob40927a crossref_primary_10_1002_jps_23681 crossref_primary_10_1021_cr500392w crossref_primary_10_1111_j_1742_4658_2011_08045_x crossref_primary_10_1080_10406638_2015_1033432 crossref_primary_10_1016_j_ejmech_2020_112984 crossref_primary_10_1080_00958972_2011_616930 crossref_primary_10_2174_1389557522666220928120727 crossref_primary_10_1007_s10847_014_0412_8 crossref_primary_10_1016_j_cclet_2014_03_012 crossref_primary_10_1016_j_mycmed_2022_101254 crossref_primary_10_1080_10426507_2012_743147 crossref_primary_10_1016_j_bmc_2011_10_031 crossref_primary_10_1016_j_cplett_2016_01_022 crossref_primary_10_36306_konjes_1039091 crossref_primary_10_1016_j_bioorg_2019_103207 crossref_primary_10_1186_2193_8865_3_72 crossref_primary_10_1016_j_bmc_2009_11_016 crossref_primary_10_1016_j_saa_2014_04_156 crossref_primary_10_1039_C4OB02611J crossref_primary_10_1039_C2CS35233H crossref_primary_10_15407_bioorganica2022_01_086 crossref_primary_10_3109_01480545_2011_653490 crossref_primary_10_1002_slct_202002881 crossref_primary_10_1080_10610278_2012_761342 crossref_primary_10_4155_ppa_2017_0034 crossref_primary_10_1007_s11743_016_1792_0 crossref_primary_10_1002_masy_201600101 crossref_primary_10_1007_s10847_010_9825_1 crossref_primary_10_1002_slct_201701306 crossref_primary_10_1016_j_colsurfb_2012_10_045 crossref_primary_10_1080_00304948_2017_1320903 crossref_primary_10_1002_ange_201206785 crossref_primary_10_1007_s10847_018_0814_0 crossref_primary_10_1016_j_tet_2015_07_077 crossref_primary_10_1021_jp204154m crossref_primary_10_1080_10406638_2023_2212106 crossref_primary_10_1111_cbdd_12267 crossref_primary_10_1002_ijch_201100040 crossref_primary_10_1016_j_bmc_2012_01_041 crossref_primary_10_1111_cbdd_12818 crossref_primary_10_1016_j_arabjc_2016_04_007 crossref_primary_10_1021_jp507151r crossref_primary_10_1039_C2CC16480A crossref_primary_10_1016_j_tetlet_2011_08_142 crossref_primary_10_1016_j_bmc_2023_117586 crossref_primary_10_1016_j_arabjc_2016_06_013 crossref_primary_10_1039_C9RA03354H crossref_primary_10_1007_s10847_011_0062_z crossref_primary_10_1007_s10847_015_0581_0 crossref_primary_10_1016_j_ejps_2012_07_015 crossref_primary_10_1002_chem_201605246 crossref_primary_10_1134_S1070428014040228 crossref_primary_10_17721_fujcV3I2P93_100 crossref_primary_10_1021_jp102471c crossref_primary_10_17721_fujcV5I2P49_55 crossref_primary_10_1021_acsinfecdis_9b00290 crossref_primary_10_1039_C5SM01891A crossref_primary_10_1080_10426507_2012_741164 crossref_primary_10_1186_s40543_017_0111_3 crossref_primary_10_15406_jnmr_2015_02_00028 crossref_primary_10_1039_C7CS00040E crossref_primary_10_1007_s10847_012_0169_x crossref_primary_10_1021_cr200213s crossref_primary_10_1039_C6CE02649D crossref_primary_10_1016_j_bmcl_2013_08_040 crossref_primary_10_1039_c2ob06730g crossref_primary_10_1039_C5RA05423K crossref_primary_10_1002_cbic_201800609 crossref_primary_10_1007_s10847_017_0773_x crossref_primary_10_14710_jksa_25_3_123_129 crossref_primary_10_1007_s00706_021_02736_4 crossref_primary_10_1016_j_jmgm_2018_06_018 crossref_primary_10_1039_c2nj40338b crossref_primary_10_1080_10406638_2018_1464037 crossref_primary_10_1016_j_saa_2014_10_100 crossref_primary_10_1002_cplu_201200141 crossref_primary_10_1016_j_molliq_2017_09_113 crossref_primary_10_1002_chem_201100154 crossref_primary_10_1002_hlca_201200044 crossref_primary_10_1007_s10847_020_01022_w crossref_primary_10_1016_j_cellsig_2024_111174 crossref_primary_10_1039_C8QO00728D crossref_primary_10_17721_fujcV7I2P61_67 crossref_primary_10_1002_ardp_201400390 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.2174/157016309788488302 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 19519339 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- .5. 0R~ 29F 4.4 53G 5GY AAEGP ABEEF ABVDF ACGFS ACITR ACIWK ACPRK AFRAH AGJNZ ALMA_UNASSIGNED_HOLDINGS ANTIV C1A CGR CS3 CUY CVF DU5 EBS ECM EIF EJD F5P GH2 HZ~ IPNFZ KCGFV NPM O9- P2P RIG |
ID | FETCH-LOGICAL-b339t-2d472e230f4fd621055aad4df5165026ef14f1d5810b9663b954c9b503a803712 |
ISSN | 1570-1638 |
IngestDate | Thu May 23 23:13:43 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b339t-2d472e230f4fd621055aad4df5165026ef14f1d5810b9663b954c9b503a803712 |
PMID | 19519339 |
ParticipantIDs | pubmed_primary_19519339 |
PublicationCentury | 2000 |
PublicationDate | 2009-Jun |
PublicationDateYYYYMMDD | 2009-06-01 |
PublicationDate_xml | – month: 06 year: 2009 text: 2009-Jun |
PublicationDecade | 2000 |
PublicationPlace | United Arab Emirates |
PublicationPlace_xml | – name: United Arab Emirates |
PublicationTitle | Current drug discovery technologies |
PublicationTitleAlternate | Curr Drug Discov Technol |
PublicationYear | 2009 |
References | Curr Drug Discov Technol. 2009 Dec;6(4):306 |
References_xml | |
SSID | ssj0029768 |
Score | 2.223597 |
SecondaryResourceType | review_article |
Snippet | Calixarenes, macrocyclic compounds of phenolic units linked by methylene groups at the 2,6-positions, present some of the requirements to serve as platforms... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 151 |
SubjectTerms | Calixarenes - chemical synthesis Calixarenes - chemistry Drug Delivery Systems Drug Design Magnetic Resonance Spectroscopy Mass Spectrometry |
Title | Calixarenes as new platforms for drug design |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19519339 |
Volume | 6 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La8JAEF60vfRS-n6XPRQvGppNNiY5Fqt4aRG00Jsk2V2x4INGof77zuyah5aW9tDLEnbDsGYmk2_GmW8JuRO-_u67lu0qbnEhpQUwJLYkT3yIPqLY0zzb3b7__Bo8tnm7Usmj_nzuXzUNc6Br7Jz9g7ZzoTAB16BzGEHrMP5K79hs9YEdXjLFM2QANeNJ0QvEppp6oS7el6O6KAo33jbpR83yOE2wthOgaZZ6LxUbClnv6D_Y2WI8MXlZLI2dbeemtYmAMxqNZ0hSAN4jv6UfQURuOmyEFuXCLVgMn4zFbCMTERYVU5nz9G0L8V3ZuzZLRuSUPCUzPLPbHhwjJEwmgCiQhE0mAbgYV3dlL0rqm0-0_liICNTQIf28usWqnS1VSRUwEsLo1lMeqANE0y2U2e8xzVa4tfuvG9O0s0bYVmiiIcrggOyvYwv6YIzikFTk9IjUeoacfNWgg6LXLm3QGu0VtOWrY9IoWQ6NUgqWQ3PLoTBSNA1qLOeEvHTag1bXWp-lYcWwsYXlCO47EuJNxZVoOngsahQJLpTH4F11mlIxrpjwAmbHEAG7cejxJIw9240CZHV0TsnOdDaV54RKL44B-CRh4gseRn6oAGLaLHHtgLNEuRfkzDyF4dwQpgyz53P57coV2Sss6prsKngb5Q2ppmJ5q3XzCWeDToQ |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Calixarenes+as+new+platforms+for+drug+design&rft.jtitle=Current+drug+discovery+technologies&rft.au=de+F%C3%A1tima%2C+Angelo&rft.au=Fernandes%2C+Sergio+Antonio&rft.au=Sabino%2C+Ad%C3%A3o+Aparecido&rft.date=2009-06-01&rft.issn=1570-1638&rft.volume=6&rft.issue=2&rft.spage=151&rft_id=info:doi/10.2174%2F157016309788488302&rft_id=info%3Apmid%2F19519339&rft_id=info%3Apmid%2F19519339&rft.externalDocID=19519339 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1570-1638&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1570-1638&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1570-1638&client=summon |